< Back to situations

[ORGANIZATION]

DNB Bank ASA

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [DK]

GLP-1 obesity drug rollout and market expansion

105 clusters · 510 sources · last updated

Latest: Novo Nordisk reports pediatric obesity trial success amid market pressure

Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima

[ACTIVE] [BUSINESS] [DK] [NO] [FI]

European firms continue share buy-backs

13 clusters · 29 sources · last updated

Latest: DNB Bank and Gabriel Holding report share buy-back updates

Throughout July and August 2026, European companies continued a trend of share buy-backs, particularly within the Scandinavian financial and industrial sectors. In the banking and financial sector, several Nordic instit

Also covered in